• Latest Posts
In Depth 11 Jan 2023

Drug repurposing emerges as viable option for rare disease treatment

In Depth 10 Jan 2023

Innovative biomaterials are revolutionizing tissue regeneration

In Depth 9 Jan 2023

The biggest private biotech investments in December 2022

In Depth 5 Jan 2023

Navignostics maps tumor proteomes to improve precision oncology

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

ADVERTISEMENT
In Depth 15 Dec 2022

To avoid stagnation, the EU must refine its ATMP regulation

In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

In Depth 1 Nov 2022

The biggest private biotech investments in October 2022

In Depth 20 Oct 2022

Opportunities and challenges for cell and gene therapy investments

ADVERTISEMENT